AAIC 2025 Abstract·26 DecSabirnetug shows superior selectivity for Aβ oligomers over monomer compared to recombinant lecanemab and aducanumabExperiments in cellsMechanismsPaper
AAIC 2025 Abstract·25 DecALTITUDE‐AD: Cost Savings Using a pTau217 Screening Assay in an Ongoing Phase 2 Study of Sabirnetug in Early Alzheimer's DiseaseTrial in peopleBiomarkersPaper
AAIC 2025 Abstract·23 DecDifferential Vascular and Non‐Vascular Binding Patterns of ACU193 and R‐Lecanemab in APP;hAPOE4 Mouse Brain SectionsExperiments in animalsMechanismsPaper